web analytics

Evaluation

Are you considering use of an anti-TNF alpha agent in a patient?

Have you informed the patient about the risk of optic neuritis and other demyelinating conditions?

Does the patient have a family or personal history of?

• multiple sclerosis?

• optic neuritis?

• transverse myelitis?

• Guillain-Barre syndrome?

• other demyelinating condition?

Is the patient instructed to immediately report?

• ocular pain?

• loss of visual acuity?

• abnormality in visual fields?

• abnormal perception of colors (dyschromatopsia)?

Has the patient given informed consent to the therapy?

Results

Please fill out required fields.